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In 1993, an outbreak of encephalitis among 125 af-
fected equids in coastal Chiapas, Mexico, resulted in a 50% 
case-fatality rate. The outbreak was attributed to Venezu-
elan equine encephalitis virus (VEEV) subtype IE, not previ-
ously associated with equine disease and death. To better 
understand the ecology of this VEEV strain in Chiapas, we 
experimentally infected 5 species of wild rodents and evalu-
ated their competence as reservoir and amplifying hosts. 
Rodents from 1 species (Baiomys musculus) showed signs 
of disease and died by day 8 postinoculation. Rodents from 
the 4 other species (Liomys salvini, Oligoryzomys fulves-
cens, Oryzomys couesi, and Sigmodon hispidus) became 
viremic but survived and developed neutralizing antibod-
ies, indicating that multiple species may contribute to VEEV 
maintenance. By infecting numerous rodent species and 
producing adequate viremia, VEEV may increase its chanc-
es of long-term persistence in nature and could increase 
risk for establishment in disease-endemic areas and ampli-
ﬁ  cation outside the disease-endemic range.
V
enezuelan equine encephalitis (VEE) is a potentially 
fatal, reemerging disease in tropical America (the por-
tions of North, South, and Central America between the 
tropics of Cancer and Capricorn) that can cause outbreaks 
involving hundreds of thousands of humans and equids. 
VEE virus (VEEV; Togaviridae: Alphavirus) strains are 
categorized as either epizootic (associated with equine dis-
ease and major epidemics of human disease through equine 
ampliﬁ   cation), or enzootic (not known to cause equine 
disease). Most VEEV strains, both epizootic and enzootic, 
have been associated with human disease (1). VEEV is 
also of biodefense importance; it has been developed as a 
biological weapon, mainly because it is highly infectious 
by aerosol transmission and can infect humans with a rela-
tively low dose (2).
During the mid-1990s, 2 epizootic equine outbreaks 
occurred in coastal Oaxaca and Chiapas states in Mexico; 
the causative agent was determined to be VEEV subtype IE 
(VEEV-IE), which was previously considered to be not vir-
ulent for equids (1). On the basis of the spread of a VEEV 
subtype IAB epizootic/epidemic through Mexico and into 
Texas in 1971 (3), the 1993 and 1996 outbreaks were con-
sidered to have the potential to spread to other regions of 
Mexico or the United States. To prevent, detect, and evalu-
ate potential reemergence of this virus in the United States, 
we need to understand the factors that govern circulation 
and persistence of this virus in its enzootic foci and epi-
zootic cycles.
Enzootic strains of VEEV are maintained naturally by 
transmission between mosquitoes of the subgenus Culex 
(Melanoconion) and wild rodents (4). These viruses are 
thought to circulate continuously among mosquitoes and 
their principal vertebrate amplifying hosts, whereas horses 
and humans are considered spillover, dead-end hosts not 
required for maintenance of the natural cycle. Several stud-
ies have shown that terrestrial mammals of 5 genera (Di-
delphis, Oryzomys, Proechimys, Sigmodon, and Zygodon-
tomys) are susceptible to VEEV-IE infection; they develop 
viremia sufﬁ  cient to infect mosquito vectors, yet they usu-
ally survive infection (5–10).
Several species of wild rodents captured in coastal 
Chiapas have VEEV-speciﬁ  c antibodies (11). To address 
which of these species are likely to play a role as reser-
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voir and/or ampliﬁ  cation hosts, we captured rodents from 
5 genera (Baiomys, Liomys, Oligoryzomys, Oryzomys, and 
Sigmodon) and transported them to the laboratory for ex-
perimental infection studies. Our goals were to evaluate the 
role of various vertebrate species in VEEV-IE maintenance 
and to help interpret seroprevalence data gathered in the 
ﬁ  eld.
Materials and Methods
Animals
During October 2007, wild rodents of 5 species were 
collected from coastal Chiapas, Mexico: Baiomys muscu-
lus (southern pygmy mouse), Liomys salvini (Salvins spiny 
pocket mouse), Oligoryzomys fulvescens (fulvus pygmy 
rice rat), Oryzomys couesi (Coues’ rice rat) and Sigmodon 
hispidus (hispid cotton rat). All animals were captured 
from an overgrown ﬁ  eld surrounding a stream in Mapaste-
pec municipality, ≈2 km from the Paciﬁ  c coast (15.413°N 
and 093.070°W) by using live-capture Sherman traps (H.B. 
Sherman Traps, Tallahassee, FL, USA). Species identiﬁ  ca-
tion was based initially on morphologic features (12) and 
later conﬁ  rmed genetically by using cytochrome-B gene 
sequences (13). Animals were housed individually and 
transported in Taconic Transit Cages (Taconic Farms, Inc., 
Hudson, NY, USA) to the Animal Biosafety Level 3 Facil-
ity at the University of Texas Medical Branch in Galves-
ton, Texas, USA. Animals were captured under permit 
number SGPA/DGVS/03858/07 Julio 2 de 2007, issued to 
J.G.E.-F.; all studies were approved by the University of 
Texas Medical Branch Institutional Animal Care and Use 
Committee.
Virus and Infection
Immediately before rodents were inoculated with vi-
rus, a baseline serum sample was taken from each rodent 
for subsequent antibody assays. For inoculation we used 
VEEV strain MX01-22 (subtype IE). This strain had been 
isolated in 2001 from a sentinel hamster in coastal Chiapas, 
Mexico, and passaged once in Vero cells to generate a suf-
ﬁ  cient volume of high-titer virus for experimentation. We 
chose this strain because it is the most recent low-passage 
isolate of VEEV from the outbreak area and because trans-
mission of this strain by VEEV mosquito vector species 
from this area has been studied (14,15). Additionally, this 
strain is genetically highly similar to the equine-virulent 
strains that were isolated during the 1993 outbreak (11) and 
caused encephalitis in horses (R. Bowen, pers. comm.).
All animals were inoculated subcutaneously in the right 
thigh with 3.2 log10 PFU of virus, a dose that approximates 
the maximum amount of VEEV transmitted by a mosquito 
bite (16). After inoculation, all animals were weighed daily 
for 1 week and observed for signs of illness for 2 weeks.
Viremia Assays
Blood was collected daily for the ﬁ  rst 7 days after in-
oculation, then on days 10, 14, 28, 42, and 66. After the ani-
mals were anesthetized with inhaled isoﬂ  urane, retroorbital 
sinus blood was collected in heparinized glass capillary 
tubes and transferred to 5 volumes of phosphate-buffered 
saline (PBS). Erythrocytes were removed by centrifugation 
to yield an ≈1:10 dilution of serum, which was stored at 
–80ºC. Viremia titers were determined by plaque assay on 
Vero cells (17).
Necropsy was performed on all animals, and tissues 
were frozen at –80ºC. Using a TissueLyser (QIAGEN Inc, 
Valencia, CA, USA), we homogenized ≈2–10 mg of tissue 
in minimal essential medium (Eagle) supplemented with 
20% fetal bovine serum, L-glutamine, penicillin, strepto-
mycin, gentamicin, and fungizone. Tissue virus titers were 
determined by plaque assay on Vero cells.
Antibody Assays
To detect VEEV-IE–speciﬁ  c antibodies, we performed 
hemagglutination inhibition assays (17) using antigen de-
rived from the same VEEV strain used for infection (MX01-
22) as well as from 3 other arboviruses: Eastern equine en-
cephalitis virus (TenBroeck strain), West Nile virus (strain 
385-99), and St. Louis encephalitis virus (strain TBH28). 
Brieﬂ  y, 4–8 units of hemagglutinin antigen were reacted 
with heat-inactivated test serum in various concentrations 
in PBS. Failure to hemagglutinate goose erythrocytes was 
considered a positive result. Antibody titers were conﬁ  rmed 
by plaque reduction neutralization tests (17). Test serum 
samples were serially diluted in PBS and heat inactivated 
at 56°C for 1 h, then mixed with ≈100 PFU of virus and 
incubated at 37°C for 1 h. The mixture was inoculated onto 
Vero cells. Dilutions resulting in >80% reduction in virus 
titer were considered positive; titers were reported as the 
reciprocal of the endpoint dilution.
Results
Clinical Responses and Survival Rates 
Of the 5 rodent species examined, only those of species 
B. musculus showed signs of disease with neurologic mani-
festations. These animals began to exhibit tremor, lethargy, 
dehydration, hunching, and staggering during days 4–6 
postinoculation. By day 8, all 4 (100%) of these B. mus-
culus rodents had died or were euthanized after becoming 
moribund (Figure 1, panel A). Rodents of this species were 
the only ones that lost body weight after inoculation (aver-
age 22% loss; Figure 1, panel B).
No animal from the other 4 species exhibited weight 
loss or outward signs of illness after inoculation. Most of 
these rodents survived until the end of the experiment, day 
66 postinoculation. However, during the ﬁ  rst 2 weeks af-
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ter inoculation, 9 animals died without weight loss or signs 
of illness. These animals did not have high levels of virus 
in their tissues (Table) and are considered to have died of 
stress from daily manipulations rather than of VEEV infec-
tion. To address this possibility, a subcohort of 2 L. salvini 
and 3 O. fulvescens rodents, the 2 species that had had the 
most manipulation-related deaths, were inoculated and ob-
served for 15 days without daily blood sampling. All 5 ani-
mals survived with little to no illness; they were found to 
have seroconverted by day 15 (reciprocal mean titer = 2.7 ± 
2.3 log10, standard error) and remained seropositive through 
day 42 (3.0 ± 2.9 log10). Similar deaths of wild rodents in 
the absence of an infectious cause have been encountered 
previously (10).
Virus Titers
Of 35 animals tested, 22 (comprising all 5 species) had 
measurable virus levels during the ﬁ  rst week after inocula-
tion (limit of detection was 1.5 log10 PFU/mL) (Figure 2). 
Viremia (>2.7 log10 PFU/mL) developed in all (100%) O. 
fulvescens, L. salvini, and B. musculus rodents and lasted as 
long as 4, 5, and 8 days, respectively. Conversely, detect-
able viremia developed in only 60% of the cohort of S. his-
pidus rodents (3/5 animals), lasting as long as 4 days, and 
in only 39% of the O. couesi cohort (7/18 animals), lasting 
as long as 2 days.
In the cohorts of L. salvini, O. fulvescens, and O. coue-
si rodents, maximum viremia occurred on day 1 postinocu-
lation; mean titers were 3.4 ± 0.6 (SEM), 3.3 ± 0.2, and 2.5 
± 0.6 log10 PFU/mL, respectively (Figure 2). In S. hispidus 
rodents, the cohort peak viremia occurred on day 2 posti-
noculation; mean was 2.9 log10 ± 0.9. In the cohort of B. 
musculus rodents, peak viremia occurred on day 3; mean 
was 5.5 ± 0.4 PFU/mL (Figure 2).
Antibody Responses 
Of the 40 animals used in this study, only 1 (S. his-
pidus) was found to have preexisting VEEV antibodies. 
This animal had a hemagglutination inhibition reciprocal 
antibody titer of 2.8 log10 on day 0 and 2.2 log10 on day 6, 
when it died during anesthesia and blood collection. For 
rodents of all 4 surviving species, antibodies were detect-
able by day 5 and lasted through the end of the experiment 
(Figure 2).
Age Dependence
An unanticipated cohort of 3 juvenile rodents (O. 
couesi) provided an opportunity to examine whether age 
affected outcome of VEEV infection. The species of these 
3 animals was initially identiﬁ  ed as O. fulvescens but later 
determined, based on cytochrome-B gene sequencing, to 
be juvenile O. couesi (13). Age at infection was ≈2 weeks, 
determined on the basis of growth of 3 litters of O. couesi 
rodents born in captivity.
No differences were found between the juvenile and 
the adult O. couesi rodents in terms of survival rates, vire-
mia levels, or antibody responses (Figures 1, 2). Viremia 
was detected in 1 (33%) of 3 juvenile and 6 (40%) of 15 
adult O. couesi rodents. Mean maximum viremia was 2.3 
log10 PFU/mL for the juveniles and 2.6 ± 0.6 log10 PFU/mL 
for the adults. No viremia was detected after day 1 for either 
juveniles or adults, except for 1 adult that had a titer of 2.6 
log10 on day 2. Antibody responses were inconsistent among 
animals from both groups. Several animals from each group 
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Figure 1. Survival rates and weight change of wild rodents from 
Chiapas, Mexico, after experimental infection with 3 log10 PFU of 
Venezuelan equine encephalitis virus subtype IE, strain MX01-22. 
A) Survival rates. Black and yellow lines represent animals whose 
brains yielded live virus after necropsy. Red, green, blue, and purple 
lines indicate animals whose death was attributed to manipulation 
and/or stress, not to VEEV infection. B) Weight change. Mean 
cohort weight (grams) divided by mean cohort starting weight 
(day 0). Weight gain or loss was used as an indicator of disease. 
Only  Baiomys musculus rodents showed weight loss during 
acute infection. Data for days 42 and 66 (not shown) did not differ 
signiﬁ  cantly from that for day 28. Error bars indicate SEM.RESEARCH
showed weak antibody responses of short duration, delayed 
onset, or both, after having no detectable viremia.
Discussion
Reservoir Status and Potential 
Of the 5 species of rodents evaluated in this study, only 
S. hispidus rodents have been included in previous experi-
mental VEEV infection studies. In Panama (10) and Florida 
(5,7), S. hispidus rodents are considered to be competent, 
mostly disease-resistant reservoir hosts for disease caused 
by sympatric VEE complex alphaviruses. In 2007, Carrara 
et al. (7) infected 3 geographically distinct populations of S. 
hispidus rodents with 2 enzootic VEEV strains and found 
that only the population from a VEE complex alphavirus–
endemic region (Florida) survived infection; cohorts from 
the 2 non–virus-endemic populations succumbed to dis-
ease. For this reason, we used a sympatric VEEV strain for 
our studies.
In addition to S. hispidus rodents, 3 other species 
(Proechimys semispinosus, Zygodontomys microtinus, and 
Oryzomys capito) had viremia sufﬁ  cient to infect at least 
some mosquito vectors and survive after inoculation with 
sympatric strains of VEEV (8–10). Our results support the 
hypothesis that enzootic VEEV selects for resistance to dis-
ease in its sympatric reservoir host populations (10).
Several ﬁ  eld studies in Mexico have reported VEEV-
speciﬁ  c antibodies in a variety of wild vertebrate species. 
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Table. Viremia in rodents that died 1–14 days after inoculation with 3.2 log10 PFU of Venezuelan equine encephalitis virus subtype IE 
strain MX01-22* 
Tissue virus content (log10 PFU/g)† 
Rodent genus  dpi†  Brain Heart  Spleen  Kidney  Liver Lung 
Oryzomys  2  1.8 2.7 3.3 2.0 3.2  0 
Oligoryzomys  4  0 0  4.0  0 0 0 
  6  0 0  3.4  0 0 0 
Baiomys  6  3.2 5.0 5.0 4.7 4.9 3.9 
  7  4.6 3.2 4.2  0  4.3 4.3 
  7  2.0 2.0 3.0 3.4 2.6 4.1 
    8  5.0 3.0 5.7 5.0 1.9 5.0 
*Not shown are 3 Liomys salvini, 2 Oligoryzomys fulvescens,  and 1 Sigmodon hispidus rodents. These animals died on days 5–10 postinoculation and 
showed no detectable virus in any organs tested. dpi, days postinoculation. 
†Limit of detection was 1 plaque in150 ȝL homogenate. Tissue sample weight varied between 0.002 and 0.01 grams. 
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Figure 2. Mean viremia proﬁ  le (red lines) and mean hemagglutination inhibition (HI) antibody proﬁ  le (blue lines) of 5 species of wild rodents 
after experimental infection with 3 log10 PFU of Venezuelan equine encephalitis virus type-IE, strain MX01-22. Black dashed lines indicate 
approximate mosquito infection viremia threshold for the enzootic vector Culex (Melanoconion) taeniopus. Fractions represent proportion 
of total cohort that had measurable response. Data for days 42 and 66 (not shown) did not differ signiﬁ  cantly from data for day 28. Error 
bars indicate SEM.Potential Reservoir Hosts, VEE, Mexico
Aguirre et al. (18) found 7 species of wild mammals and 17 
species of wild birds that were seropositive against VEEV-
IE in 1992. In the same area from which the animals for our 
study were captured, VEEV-neutralizing antibodies were 
detected in wild S. hispidus, Oryzomys alfaroi, and Didel-
phis marsupialis rodents (11). In an extensive ﬁ  eld study in 
southern Mexico during the 1960s, Scherer et al. (6) found 
29 species of wild birds, 10 genera of terrestrial mammals, 
and 3 genera of bats with serologic evidence of natural 
VEEV infection. Evidence of similar broad host ranges 
of VEEV has been found in coastal Guatemala, where 7 
genera of terrestrial mammals and 11 species of birds had 
VEEV-speciﬁ  c antibodies (19). After the 1971 epidemic 
of VEEV-IAB that started in Central America and reached 
southern Texas, extensive ﬁ  eld studies were conducted to 
determine whether the virus would or could establish a new 
enzootic focus (20). In that study, mammals of 10 genera 
had VEEV-speciﬁ  c antibodies. In 2 follow-up studies in 
which wild mammals and wild birds were infected with a 
strain of VEEV-IB isolated during the outbreak, viremia 
and mortality rates for rodents were high (21,22). In a lon-
gitudinal ﬁ  eld study performed concurrent with the study 
reported here, seroprevalance for wild rodents was found to 
be much lower than previously found for this area (11).
Viremia and Immunologic Response
All 5 of the species tested produced viremia titers suf-
ﬁ  cient to infect the proven enzootic mosquito vector Cx. 
(Mel.) taeniopus. Of these 5 species, the lowest and shortest 
lasting viremia was found in O. couesi rodents; however, 
even these reached levels that are considered adequate to 
infect a proportion of Cx. (Mel.) taeniopus (23). The other 4 
species all exhibited viremia titers well above the minimum 
infection threshold for this vector. Therefore, assuming that 
they are bitten by Cx. (Mel.) taeniopus mosquitoes, which 
are known to be universal feeders and have been recently 
found in higher numbers than previously reported in the 
area where these animals were captured, all 5 species we 
studied should be able to infect this mosquito (11,24).
The uniform susceptibility of B. musculus rodents to 
VEE disease was an unexpected result and appeared to 
contradict the hypothesis that VEEV circulation selects for 
resistance to disease in wild rodents. This difference is evi-
dently not reﬂ  ective of the taxonomic relatedness of these 
5 species (Figure 3). A different potential explanation is 
the lack of temporal overlap of activity between B. mus-
culus rodents and the enzootic vector, Cx. (Mel.) taenio-
pus. Baiomys spp. rodents are diurnally active (12), but Cx. 
(Mel.) taeniopus mosquitoes are nocturnal feeders (24,25). 
Although the rodents and mosquito vectors coexist spatial-
ly, they are not active at the same time of day, which may 
limit their contact. This lack of contact time may preclude 
the selection for resistance to VEE that is manifested in the 
other 4 rodent species, which are nocturnal and presumably 
regularly exposed to bites from this vector. Experimental 
infection of other diurnal species from the study area, or 
similar studies in another VEE-endemic area, could be used 
to test this hypothesis. Of the 5 species, B. musculus ro-
dents were the only species not encountered in previous 
capture-and-release studies; however, because of the sever-
ity of disease in this species, seropositive individuals would 
be unlikely to survive (and thereby be caught) in the wild.
We ended our study at 66 days postinoculation for the 
original cohort and 42 days postinoculation for the subco-
horts of L. salvini and O. fulvescens that survived. The an-
tibody responses for all animals that developed measurable 
viremia persisted through the end of the experiment. The 
only exception was several O. couesi animals that did not 
develop viremia but did demonstrate brief, low-titer (<1.6 
log10) antibody responses. Wild rodents have been shown to 
remain seropositive for as many as 6 months postinocula-
tion with VEEV (7). For some species with short life spans 
in the wild, this antibody response is tantamount to life-
long immunity offering protection against reinfection and 
affording more opportunity for the animal to reproduce.
Ecological Implications
Although the ability of laboratory experimentation to 
elucidate natural processes is limited, data gathered in the 
laboratory are sometimes more complete and detailed than 
ﬁ  eld data. In this study, 5 of the most commonly captured 
rodent species in coastal Chiapas, Mexico, were evaluated 
for their ability to participate in the natural transmission cy-
cle of enzootic VEEV-IE. S. hispidus and O. capito rodents 
have previously been implicated in ampliﬁ  cation of other 
VEE subtypes, ID, IE, and II (7–9), but the other 3 species 
(B. musculus, L. salvini, and O. fulvescens) had been stud-
ied little or not at all. Rodents of all 5 species developed 
viremia titers sufﬁ  cient to infect the enzootic mosquito vec-
tor, Cx. (Mel.) taeniopus. However, only 4 of the 5 species 
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Rodentia FAMILY
Cricetidae
FAMILY
Heteromyidae
SUBFAMILY
Sigmodontinae
SUBFAMILY
Neotominae
SUBFAMILY
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TRIBE
Sigmodontini
TRIBE
Oryzomini
TRIBE
Baiomini
GENUS Oryzomys
GENUS Sigmodon
  
FAMILY
Echymyidae
SUBFAMILY
Eumysopinae
GENUS Proechymys
GENUS Zygodontomys
GENUS Liomys
GENUS Baiomys
GENUS Oligoryzomys 
Figure 3. Relatedness of 7 wild rodent genera that have been 
experimentally evaluated for suitability as amplifying hosts in 
enzootic transmission cycles of Venezuelan equine encephalitis 
virus. The 5 genera included in this study are presented in boldface; 
the 3 novel genera are underlined. RESEARCH
survived infection with the potential to reproduce, a trait 
considered critical for true reservoir status in that it avoids 
population declines that might jeopardize long-term virus 
circulation.
History has shown that an outbreak of highly virulent 
VEEV in southern Mexico can easily and rapidly spread 
into the United States, as it did in 1971. Therefore, a better 
understanding of VEEV ecology in Mexico is essential for 
assessing the risk for widespread disease. Our results sup-
port the conclusions of Scherer et al. (6) that VEEV has a 
wide range of mammalian hosts that may participate in the 
natural transmission cycle. This strategy may be an adap-
tive one that affords greater population stability than does 
specialization for 1 amplifying host species. By being able 
to infect numerous rodent species and produce adequate 
viremia for mosquito transmission, VEEV may increase its 
chances of long-term persistence in nature when weather or 
environmental conditions affect some but not all reservoir 
host populations. This ability could also increase the risk 
for endemic establishment as well as ampliﬁ  cation when 
outbreaks spread outside their disease-endemic range.
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